On ECHEMI
Home > Drugs > Adult chronic myeloid leukemia
Adult chronic myeloid leukemia
CML, characterized by splenomegaly, anemia, and granulocytosis, was recognized by clinicians in 1845. CML accounts for 15% to 20% of all leukemias. In children, CML can manifest as two types: adult CML (ACML) and JMML. JMML is limited to children and has unique clinical, laboratory, and cytogenetic characteristics.
  • Site of disease:

    Bone marrow blood vessels lymph
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    General discomfort fatigue weight loss fever swollen lymph nodes
Related Drugs
Thioguanine Tablets
Indication: 1. The induction remission phase and continued treatment phase of acute lymphocytic leukemia and acute non-lymphocytic leukemia. 2. The chronic phase and blast phase of chronic myeloid leukemia.
Agui Yangxue Granule
Manufacturer:

Beijing Yubentang Holding Group Co., Ltd.

Ubenimex Capsules
Indication: This product can enhance immune function and is used for adjuvant therapy of anti-cancer chemotherapy and radiotherapy, elderly immune deficiency, etc. It can be used in conjunction with chemotherapy, radiotherapy and in combination with leukemia, multiple myeloma, myelodysplastic syndrome, hematopoietic stem cell transplantation, and other solid tumor patients.
Manufacturer:

Chengdu Easton Bio Pharmaceuticals Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.